MedEvidence! Truth Behind the Data

Send us Fan Mail
What happens when a Harvard-trained psychiatrist follows the evidence beyond traditional medicine?
In this episode of MedEvidence, Dr. Michael Koren sits down with Dr. Carol Locke, physician entrepreneur and Chief Science Officer of OmegaBrite, to explore her remarkable journey from psychiatry and academic research at Harvard’s McLean Hospital to pioneering evidence-based omega-3 innovation.
Dr. Locke shares how clinical research into mood disorders led to surprising discoveries about omega-3 fatty acids, brain health, inflammation, stress response, and emotional resilience. Together, they break down the science behind omega-3 balance, the role of EPA and DHA, third-party testing, and what clinical trials reveal about omega-3 supplementation’s impact on mood, anxiety, inflammation, and overall wellness.
You’ll also hear insights on physician entrepreneurship, innovation in nutraceutical science, and why evidence-based quality matters when choosing supplements.
In this episode:
 How omega-3s influence brain function and mood 
 The link between inflammation, stress, and mental health 
 What clinical trials reveal about omega-3 supplementation 
 Why supplement purity and testing matter 
 Emerging science on omega-3 delivery to the brain 
 Advice for physicians pursuing innovation 
Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us Fan Mail
When T.J. Sharpe was diagnosed with stage 4 melanoma at just 37 years old, the statistics were devastating. With a newborn son, a two-year-old daughter, and limited treatment options available at the time, he faced a life-changing decision: pursue standard chemotherapy or take a chance on early immunotherapy clinical trials.
In this powerful episode of the MedEvidence Podcast, cardiologist and medical researcher Michael Koren sits down with T.J. to discuss his remarkable journey from cancer recurrence and uncertainty to becoming a long-term survivor through groundbreaking clinical research.
Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us Fan Mail
Watch the recorded presentation of “The Liver Fats Domino Effect” featuring Dr. Mitchell Rothstein and Dr. Michael Koren.

In this educational luncheon event, the speakers discuss how fatty liver disease can progressively worsen over time, from early fat accumulation in the liver to inflammation, fibrosis, cirrhosis, and, in severe cases, liver transplant.

This presentation also explores:
- Who may be at risk for fatty liver disease
- The connection between liver health, obesity, and metabolic conditions
- Why fatty liver disease is often called a “silent” condition
- Current and emerging research treatments available in Jacksonville

Whether you are interested in liver health, clinical research, or learning more about fatty liver disease, this recorded session provides valuable insight into one of the fastest-growing liver conditions worldwide.
Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us Fan Mail
Snoring might be the sound you notice, but the real danger of obstructive sleep apnea is what you don’t hear: your brain repeatedly yanking you out of deep sleep to keep you breathing, over and over, all night long. Dr. Mitchell Rothstein, a board-certified pulmonary and sleep medicine physician, joins us to give a clear update on what modern sleep medicine understands about sleep apnea and why it has become so widespread as BMI rises in the community. 

If you found this helpful, subscribe, and share the episode with someone who wakes up exhausted.
Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!

Send us Fan Mail
Javonte Maynor joins family doctor and medical marijuana expert Dr. Erich Schramm to discuss the changing space of marijuana research and medical marijuana in the United States. The duo discuss the frustration with politics entering the medical space when it comes to marijuana, and how changing administrations can delay research. The two get into the nuts and bolts of marijuana research, including the hoops needed to perform research, conditions being treated, and a study that may be coming soon. Dr. Schramm also explains his role prescribing marijuana for the last several years and what that entails from a legal standpoint. The two then imagine what may happen to these processes if marijuana is rescheduled from a Schedule 1 to a prescribable Schedule 3 drug; including to dispensaries, the pharmaceutical industry, and current prescribing doctors.
Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!